MRNA

Underperforming stock considering market fall and participation of the fall.

Relatively Under performer.

testing 78.6% retracement looks to be on charts.

114-100 key support levels to stall the fall.

If recovery happen at the support good.

RSI hitting oversold on weekly chart as shown will be critical along support support 114-110.

If the recovery has to happen then from 78.6%

Chance for entry as long as 100 is not violated comprehensively.